Clinical trial
Recombinant Human Keratinocyte Growth Factor in Unrelated and Related…
NCT00056875 · University of Michigan, Other · Completed
Key facts
| NCT number | NCT00056875 |
|---|---|
| Title | Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants |
| Official title | Safety and Efficacy of Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants |
| Lead sponsor | University of Michigan, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Graft Versus Host Disease |
| Intervention type | Drug |
| Interventions | recombinant human keratinocyte growth factor |
| Enrollment | 50 |
| Start date | Sep 1, 2002 |
| Completion | Jun 1, 2005 |
| First posted | Mar 27, 2003 |
| Last update posted | Mar 25, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: